176 related articles for article (PubMed ID: 12205422)
1. Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion.
Vaccaro AR; Anderson DG; Toth CA
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S59-65. PubMed ID: 12205422
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications.
McKay B; Sandhu HS
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S66-85. PubMed ID: 12205423
[No Abstract] [Full Text] [Related]
3. The effect of osteogenic protein-1 in instrumented and noninstrumented posterolateral fusion in rabbits.
Jenis LG; Wheeler D; Parazin SJ; Connolly RJ
Spine J; 2002; 2(3):173-8. PubMed ID: 14589490
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins for spinal fusion.
Carlisle E; Fischgrund JS
Spine J; 2005; 5(6 Suppl):240S-249S. PubMed ID: 16291119
[TBL] [Abstract][Full Text] [Related]
5. Successful transpedicular lumbar interbody fusion by means of a composite of osteogenic protein-1 (rhBMP-7) and hydroxyapatite carrier: a comparison with autograft and hydroxyapatite in the sheep spine.
Blattert TR; Delling G; Dalal PS; Toth CA; Balling H; Weckbach A
Spine (Phila Pa 1976); 2002 Dec; 27(23):2697-705. PubMed ID: 12461396
[TBL] [Abstract][Full Text] [Related]
6. A pilot study evaluating the safety and efficacy of OP-1 Putty (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis for degenerative spondylolisthesis.
Vaccaro AR; Patel T; Fischgrund J; Anderson DG; Truumees E; Herkowitz HN; Phillips F; Hilibrand A; Albert TJ; Wetzel T; McCulloch JA
Spine (Phila Pa 1976); 2004 Sep; 29(17):1885-92. PubMed ID: 15534410
[TBL] [Abstract][Full Text] [Related]
7. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies.
Johnsson R; Strömqvist B; Aspenberg P
Spine (Phila Pa 1976); 2002 Dec; 27(23):2654-61. PubMed ID: 12461391
[TBL] [Abstract][Full Text] [Related]
8. Histologic evaluation of the efficacy of rhBMP-2 compared with autograft bone in sheep spinal anterior interbody fusion.
Sandhu HS; Toth JM; Diwan AD; Seim HB; Kanim LE; Kabo JM; Turner AS
Spine (Phila Pa 1976); 2002 Mar; 27(6):567-75. PubMed ID: 11884903
[TBL] [Abstract][Full Text] [Related]
9. The 2002 Marshall Urist Young Investigator Award Paper. Lumbar arthrodesis gene expression: a comparison of autograft with osteogenic protein-1.
White AP; Weinstein MA; Patel TCh; Horowitz MC; Friedlaender GE
Clin Orthop Relat Res; 2004 Dec; (429):330-7. PubMed ID: 15577505
[TBL] [Abstract][Full Text] [Related]
10. Safety profile for the clinical use of bone morphogenetic proteins in the spine.
Poynton AR; Lane JM
Spine (Phila Pa 1976); 2002 Aug; 27(16 Suppl 1):S40-8. PubMed ID: 12205419
[TBL] [Abstract][Full Text] [Related]
11. Graft options in posterolateral and posterior interbody lumbar fusion.
Rihn JA; Kirkpatrick K; Albert TJ
Spine (Phila Pa 1976); 2010 Aug; 35(17):1629-39. PubMed ID: 20628336
[TBL] [Abstract][Full Text] [Related]
12. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
[TBL] [Abstract][Full Text] [Related]
13. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion.
Martin GJ; Boden SD; Titus L
Spine (Phila Pa 1976); 1999 Nov; 24(21):2188-93; discussion 2193-4. PubMed ID: 10562982
[TBL] [Abstract][Full Text] [Related]
15. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions.
Cook SD; Dalton JE; Tan EH; Whitecloud TS; Rueger DC
Spine (Phila Pa 1976); 1994 Aug; 19(15):1655-63. PubMed ID: 7973957
[TBL] [Abstract][Full Text] [Related]
17. How does recombinant human bone morphogenetic protein-4 enhance posterior spinal fusion?
Cheng JC; Guo X; Law LP; Lee KM; Chow DH; Rosier R
Spine (Phila Pa 1976); 2002 Mar; 27(5):467-74. PubMed ID: 11880831
[TBL] [Abstract][Full Text] [Related]
18. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins and spinal surgery.
Sandhu HS
Spine (Phila Pa 1976); 2003 Aug; 28(15 Suppl):S64-73. PubMed ID: 12897477
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
Dawson E; Bae HW; Burkus JK; Stambough JL; Glassman SD
J Bone Joint Surg Am; 2009 Jul; 91(7):1604-13. PubMed ID: 19571082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
